BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23283958)

  • 1. Evolution of CD8+ T cell responses after acute PARV4 infection.
    Simmons R; Sharp C; Levine J; Bowness P; Simmonds P; Cox A; Klenerman P
    J Virol; 2013 Mar; 87(6):3087-96. PubMed ID: 23283958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo.
    Simmons R; Sharp C; Sims S; Kloverpris H; Goulder P; Simmonds P; Bowness P; Klenerman P
    J Infect Dis; 2011 May; 203(10):1378-87. PubMed ID: 21502079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.
    Sharp CP; Lail A; Donfield S; Simmons R; Leen C; Klenerman P; Delwart E; Gomperts ED; Simmonds P
    J Infect Dis; 2009 Oct; 200(7):1119-25. PubMed ID: 19691429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin G and M antibodies to human parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 infection.
    Yang SJ; Hung CC; Chang SY; Lee KL; Chen MY
    J Clin Virol; 2011 May; 51(1):64-7. PubMed ID: 21353629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in shanghai.
    Yu X; Zhang J; Hong L; Wang J; Yuan Z; Zhang X; Ghildyal R
    PLoS One; 2012; 7(1):e29474. PubMed ID: 22235298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parvovirus 4 infection and clinical outcome in high-risk populations.
    Simmons R; Sharp C; McClure CP; Rohrbach J; Kovari H; Frangou E; Simmonds P; Irving W; Rauch A; Bowness P; Klenerman P;
    J Infect Dis; 2012 Jun; 205(12):1816-20. PubMed ID: 22492853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of novel human parvovirus (PARV4) in Danish mothers and children.
    von Linstow ML; Rosenfeldt V; Lindberg E; Jensen L; Hedman L; Li X; Väisänen E; Hedman K; Norja P
    J Clin Virol; 2015 Apr; 65():23-5. PubMed ID: 25766982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples.
    Maple PA; Beard S; Parry RP; Brown KE
    Transfusion; 2013 Oct; 53(10 Pt 2):2575-84. PubMed ID: 23721256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of human parvovirus 4 VP2 virus-like particles in yeast and their evaluation as an antigen for detection of virus-specific antibodies in human serum.
    Tamošiūnas PL; Simutis K; Kodzė I; Firantienė R; Emužytė R; Petraitytė-Burneikienė R; Zvirblienė A; Sasnauskas K
    Intervirology; 2013; 56(5):271-7. PubMed ID: 23941824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parvovirus PARV4 visualization and detection.
    Tuke PW; Parry RP; Appleton H
    J Gen Virol; 2010 Feb; 91(Pt 2):541-4. PubMed ID: 19846677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of human bocaviruses and parvovirus 4 in solid tissues.
    Norja P; Hedman L; Kantola K; Kemppainen K; Suvilehto J; Pitkäranta A; Aaltonen LM; Seppänen M; Hedman K; Söderlund-Venermo M
    J Med Virol; 2012 Aug; 84(8):1267-73. PubMed ID: 22711355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of human parvovirus 4 viremia in the follow-up blood samples from seropositive individuals suggests the existence of persistent viral replication or reactivation of latent viral infection.
    Chen MY; Hung CC; Lee KL
    Virol J; 2015 Jun; 12():94. PubMed ID: 26088443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenicity study of the yeast-generated human parvovirus 4 (PARV4) virus-like particles.
    Lazutka J; Simutis K; Matulis P; Petraitytė-Burneikienė R; Kučinskaitė-Kodzė I; Simanavičius M; Tamošiunas PL
    Virus Res; 2021 Jan; 292():198236. PubMed ID: 33242523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PARV4 prevalence, phylogeny, immunology and coinfection with HIV, HBV and HCV in a multicentre African cohort.
    Sharp CP; Gregory WF; Hattingh L; Malik A; Adland E; Daniels S; van Zyl A; Carlson JM; Wareing S; Ogwu A; Shapiro R; Riddell L; Chen F; Ndung'u T; Goulder PJR; Klenerman P; Simmonds P; Jooste P; Matthews PC
    Wellcome Open Res; 2017 Apr; 2():26. PubMed ID: 28497124
    [No Abstract]   [Full Text] [Related]  

  • 15. No evidence of presence of parvovirus 4 in a Swedish cohort of severely immunocompromised children and adults.
    Tolfvenstam T; Norbeck O; Ohrmalm L
    PLoS One; 2012; 7(9):e46430. PubMed ID: 23050026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of human parvovirus 4 (PARV4) viremia among HBV-infected patients and healthy donors in Shiraz, Iran.
    Amirahmadi F; Sarvari J; Hosseini SY; Pirbonyeh N; Gorzin AA
    Turk J Med Sci; 2017 Jun; 47(3):868-873. PubMed ID: 28618736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus.
    Manning A; Willey SJ; Bell JE; Simmonds P
    J Infect Dis; 2007 May; 195(9):1345-52. PubMed ID: 17397006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.
    Lindner J; Barabas S; Saar K; Altmann D; Pfister A; Fleck M; Deml L; Modrow S
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):356-61. PubMed ID: 16316401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human parvovirus 4 infection, Cameroon.
    Lavoie M; Sharp CP; Pépin J; Pennington C; Foupouapouognigni Y; Pybus OG; Njouom R; Simmonds P
    Emerg Infect Dis; 2012 Apr; 18(4):680-3. PubMed ID: 22469425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: a study of parvovirus B19.
    Kasprowicz V; Isa A; Tolfvenstam T; Jeffery K; Bowness P; Klenerman P
    J Virol; 2006 Nov; 80(22):11209-17. PubMed ID: 16943301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.